This information is disseminated under the sponsorship of the U.S. Department of Transportation
in the interest of information exchange.
The United States Government assumes no Liability for the contents or use thereof.
Carbamazepine-10, 11-epoxide |
| Description |
Metabolite of Carbamazepine |
| Therapeutic Low |
0.0000 |
| Therapeutic High |
0.0000 |
| Units |
ug/mL |
| Specimen |
P |
| Half Life Low |
0.00 |
| Half Life High |
0.00 |
| VOD Low |
0.00 |
| VOD High |
0.00 |
| Toxic Level |
0.000 |
| Lethal Level |
0.000 |
| Plasma to Whole Blood ratio |
0.00 |
| Warnings |
Common adverse effects may include drowsiness, headaches and migraines, motor coordination impairment, and/or upset stomach. |